GURUFOCUS.COM » STOCK LIST » USA » NYSE » DaVita Inc (NYSE:DVA) » Definitions » 6-1 Month Momentum %
Switch to:

DaVita (NYSE:DVA) 6-1 Month Momentum %

: 32.46% (As of Today)
View and export this data going back to 1995. Start your Free Trial

6-1 Month Momentum % is the total return of the stock from 6-month ago to 1-month ago. As of today (2023-09-24), DaVita's 6-1 Month Momentum % is 32.46%.

The industry rank for DaVita's 6-1 Month Momentum % or its related term are showing as below:

DVA's 6-1 Month Momentum % is ranked better than
84.4% of 673 companies
in the Healthcare Providers & Services industry
Industry Median: -2.34 vs DVA: 32.46

Competitive Comparison

For the Medical Care Facilities subindustry, DaVita's 6-1 Month Momentum %, along with its competitors' market caps and 6-1 Month Momentum % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DaVita 6-1 Month Momentum % Distribution

For the Healthcare Providers & Services industry and Healthcare sector, DaVita's 6-1 Month Momentum % distribution charts can be found below:

* The bar in red indicates where DaVita's 6-1 Month Momentum % falls in comparison to its industry or sector. The grey bar indicates the 6-1 Month Momentum %'s extreme value range as defined by GuruFocus.

DaVita  (NYSE:DVA) 6-1 Month Momentum % Calculation

6-1 Month Momentum % is calculated as following:

6-1 Month Momentum %=( Price 1-month ago / Price 6-month ago - 1 ) * 100 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DaVita  (NYSE:DVA) 6-1 Month Momentum % Explanation

Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 6-1 Month Momentum % measures the total return to a stock over the past six months, but ignores the previous month.

The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.

DaVita 6-1 Month Momentum % Related Terms

Thank you for viewing the detailed overview of DaVita's 6-1 Month Momentum % provided by Please click on the following links to see related term pages.

DaVita (NYSE:DVA) Business Description

DaVita logo
Traded in Other Exchanges
2000 16th Street, Denver, CO, USA, 80202
DaVita is the largest provider of dialysis services in the United States, boasting market share that eclipses 35% when measured by both patients and clinics. The firm operates over 3,000 facilities worldwide, mostly in the U.S., and treats over 240,000 patients globally each year. Government payers dominate U.S. dialysis reimbursement. DaVita receives about two thirds of U.S. sales at government (primarily Medicare) reimbursement rates, with the remainder coming from commercial insurers. However, while commercial insurers represented only about 10% of the U.S. patients treated, they represent nearly all of the profits generated by DaVita in the U.S. dialysis business.
Wendy Lee Schoppert director 6105 TRENTON LANE NORTH, MINNEAPOLIS MN 55442
Adam H Schechter director 2000 GALLOPING HILL ROAD, KENILWORTH NJ 07033
Jason M. Hollar director 3333 BEVERLY ROAD, HOFFMAN ESTATES IL 60179
Gregory J. Moore director 130 EAST RANDOLPH STREET, SUITE 1000, CHICAGO IL 60601
Shawn M Guertin director TRINET GROUP, INC., ONE PARK PLACE, SUITE 600, DUBLIN CA 94568
Paula A Price director ONE CVS DRIVE, WOONSOCKET RI 02895
John D Winstel officer: Chief Accounting Officer 2000 16TH STREET, DENVER CO 80202
Michael David Staffieri officer: Chief Operating Officer, DKC 2000 16TH STREET, DENVER CO 80202
Joel Ackerman officer: Chief Financial Officer COVENTRY HEALTH CARE, INC., 6705 ROCKLEDGE DR SUITE 900, BETHESDA MD 20817
Kathleen Alyce Waters officer: Chief Legal Officer C/O DAVITA INC., 2000 16TH STREET, DENVER CO 80202
James O Hearty officer: Chief Compliance Officer 2000 16TH STREET, DENVER CO 80202
Charles Berg director, officer: Executive Chair, DMG 48 MONROE TURNPIKE, TRUMBULL CT 06611
Leanne M Zumwalt officer: Grp VP, Purch & Public Affairs C/O THE ADVISORY BOARD CO WATERGATGE, 600 NEW HAMPSHIRE AVE NW, WASHINGTON DC 20037
Kent J Thiry director, officer: Chairman and CEO C/O TOTAL RENAL CARE HOLDINGS INC, 21250 HAWTHORNE BLVD, TORRANCE CA 90503
James K Hilger officer: Chief Accounting Officer